How can we improve oncofertility care for patients? A systematic scoping review of current international practice and models of care.
communication
fertility preservation
late effects
models of care
oncofertility
survivorship
systematic review
training
Journal
Human reproduction update
ISSN: 1460-2369
Titre abrégé: Hum Reprod Update
Pays: England
ID NLM: 9507614
Informations de publication
Date de publication:
01 03 2019
01 03 2019
Historique:
received:
31
05
2018
revised:
15
10
2018
accepted:
24
10
2018
pubmed:
22
11
2018
medline:
14
5
2020
entrez:
22
11
2018
Statut:
ppublish
Résumé
Fertility preservation (FP) is an important quality of life issue for cancer survivors of reproductive age. Despite the existence of broad international guidelines, the delivery of oncofertility care, particularly amongst paediatric, adolescent and young adult patients, remains a challenge for healthcare professionals (HCPs). The quality of oncofertility care is variable and the uptake and utilization of FP remains low. Available guidelines fall short in providing adequate detail on how oncofertility models of care (MOC) allow for the real-world application of guidelines by HCPs. The aim of this study was to systematically review the literature on the components of oncofertility care as defined by patient and clinician representatives, and identify the barriers, facilitators and challenges, so as to improve the implementation of oncofertility services. A systematic scoping review was conducted on oncofertility MOC literature published in English between 2007 and 2016, relating to 10 domains of care identified through consumer research: communication, oncofertility decision aids, age-appropriate care, referral pathways, documentation, training, supportive care during treatment, reproductive care after cancer treatment, psychosocial support and ethical practice of oncofertility care. A wide range of electronic databases (CINAHL, Embase, PsycINFO, PubMed, AEIPT, Education Research Complete, ProQuest and VOCED) were searched in order to synthesize the evidence around delivery of oncofertility care. Related citations and reference lists were searched. The review was undertaken following registration (International prospective register of systematic reviews (PROSPERO) registration number CRD42017055837) and guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). A total of 846 potentially relevant studies were identified after the removal of duplicates. All titles and abstracts were screened by a single reviewer and the final 147 papers were screened by two reviewers. Ten papers on established MOC were identified amongst the included papers. Data were extracted from each paper and quality scores were then summarized in the oncofertility MOC summary matrix. The results identified a number of themes for improving MOC in each domain, which included: the importance of patients receiving communication that is of a higher quality and in different formats on their fertility risk and FP options; improving provision of oncofertility care in a timely manner; improving access to age-appropriate care; defining the role and scope of practice of all HCPs; and improving communication between different HCPs. Different forms of decision aids were found useful for assisting patients to understand FP options and weigh up choices. This analysis identifies core components for delivery of oncofertility MOC. The provision of oncofertility services requires planning to ensure services have safe and reliable referral pathways and that they are age-appropriate and include medical and psychological oncofertility care into the survivorship period. In order for this to happen, collaboration needs to occur between clinicians, allied HCPs and executives within paediatric and adult hospitals, as well as fertility clinics across both public and private services. Training of both cancer and non-cancer HCPs is needed to improve the knowledge of HCPs, the quality of care provided and the confidence of HCPs with these consultations.
Sections du résumé
BACKGROUND
Fertility preservation (FP) is an important quality of life issue for cancer survivors of reproductive age. Despite the existence of broad international guidelines, the delivery of oncofertility care, particularly amongst paediatric, adolescent and young adult patients, remains a challenge for healthcare professionals (HCPs). The quality of oncofertility care is variable and the uptake and utilization of FP remains low. Available guidelines fall short in providing adequate detail on how oncofertility models of care (MOC) allow for the real-world application of guidelines by HCPs.
OBJECTIVE AND RATIONALE
The aim of this study was to systematically review the literature on the components of oncofertility care as defined by patient and clinician representatives, and identify the barriers, facilitators and challenges, so as to improve the implementation of oncofertility services.
SEARCH METHODS
A systematic scoping review was conducted on oncofertility MOC literature published in English between 2007 and 2016, relating to 10 domains of care identified through consumer research: communication, oncofertility decision aids, age-appropriate care, referral pathways, documentation, training, supportive care during treatment, reproductive care after cancer treatment, psychosocial support and ethical practice of oncofertility care. A wide range of electronic databases (CINAHL, Embase, PsycINFO, PubMed, AEIPT, Education Research Complete, ProQuest and VOCED) were searched in order to synthesize the evidence around delivery of oncofertility care. Related citations and reference lists were searched. The review was undertaken following registration (International prospective register of systematic reviews (PROSPERO) registration number CRD42017055837) and guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).
OUTCOMES
A total of 846 potentially relevant studies were identified after the removal of duplicates. All titles and abstracts were screened by a single reviewer and the final 147 papers were screened by two reviewers. Ten papers on established MOC were identified amongst the included papers. Data were extracted from each paper and quality scores were then summarized in the oncofertility MOC summary matrix. The results identified a number of themes for improving MOC in each domain, which included: the importance of patients receiving communication that is of a higher quality and in different formats on their fertility risk and FP options; improving provision of oncofertility care in a timely manner; improving access to age-appropriate care; defining the role and scope of practice of all HCPs; and improving communication between different HCPs. Different forms of decision aids were found useful for assisting patients to understand FP options and weigh up choices.
WIDER IMPLICATIONS
This analysis identifies core components for delivery of oncofertility MOC. The provision of oncofertility services requires planning to ensure services have safe and reliable referral pathways and that they are age-appropriate and include medical and psychological oncofertility care into the survivorship period. In order for this to happen, collaboration needs to occur between clinicians, allied HCPs and executives within paediatric and adult hospitals, as well as fertility clinics across both public and private services. Training of both cancer and non-cancer HCPs is needed to improve the knowledge of HCPs, the quality of care provided and the confidence of HCPs with these consultations.
Identifiants
pubmed: 30462263
pii: 5193422
doi: 10.1093/humupd/dmy038
pmc: PMC6390168
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
159-179Subventions
Organisme : Medical Research Council
ID : G1100357
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : P50 HD076188
Pays : United States
Informations de copyright
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.
Références
Fertil Steril. 2014 May;101(5):1237-43
pubmed: 24684955
Breast Cancer. 2013 Jul;20(3):230-40
pubmed: 22271066
J Psychosoc Oncol. 2016 Sep-Oct;34(5):347-62
pubmed: 27269305
Curr Oncol. 2012 Jun;19(3):155-9
pubmed: 22670094
Support Care Cancer. 2013 Sep;21(9):2477-84
pubmed: 23604520
Clin J Oncol Nurs. 2008 Jun;12(3):467-76
pubmed: 18515245
JCO Glob Oncol. 2020 Mar 2;6:
pubmed: 32259156
Eur J Cancer Care (Engl). 2016 Jan;25(1):99-111
pubmed: 26361092
Pediatr Blood Cancer. 2018 Nov;65(11):e27297
pubmed: 29972282
Int J Clin Oncol. 2015 Feb;20(1):82-9
pubmed: 24562526
Eur J Cancer. 2012 Dec;48(18):3355-77
pubmed: 23116682
JCO Glob Oncol. 2020 Mar 2;6:
pubmed: 32259160
Clin Pediatr (Phila). 2008 Apr;47(3):302-5
pubmed: 18057149
Int J Gynaecol Obstet. 2010 May;109(2):118-20
pubmed: 20152978
Support Care Cancer. 2012 Jun;20(6):1259-65
pubmed: 21660668
Br J Cancer. 2013 Mar 19;108(5):1004-11
pubmed: 23470465
Breast. 2016 Jun;27:22-6
pubmed: 27212696
J Cancer Surviv. 2007 Jun;1(2):146-55
pubmed: 18648955
J Pediatr Oncol Nurs. 2008 Mar-Apr;25(2):102-6
pubmed: 18270309
J Hum Reprod Sci. 2016 Jul-Sep;9(3):179-186
pubmed: 27803586
Acta Oncol. 2015 Feb;54(2):243-52
pubmed: 25140859
Hum Reprod. 2008 Apr;23(4):772-4
pubmed: 18321893
Hum Reprod. 2016 Feb;31(2):403-11
pubmed: 26677956
Hum Fertil (Camb). 2010 Sep;13(3):151-8
pubmed: 20849200
J Reprod Infertil. 2011 Jan;12(1):33-6
pubmed: 23926497
J Adolesc Young Adult Oncol. 2016 Jun;5(2):187-200
pubmed: 26812462
Gynecol Endocrinol. 2014 Nov;30(11):822-4
pubmed: 25054374
J Assist Reprod Genet. 2016 Feb;33(2):265-80
pubmed: 26560157
J Cancer Educ. 2016 Mar;31(1):115-22
pubmed: 25934223
Support Care Cancer. 2016 Aug;24(8):3353-60
pubmed: 26980331
Eur J Obstet Gynecol Reprod Biol. 2015 Nov;194:78-84
pubmed: 26342681
Gynecol Endocrinol. 2013 Apr;29(4):285-91
pubmed: 23347067
Soc Work Health Care. 2008;47(4):479-501
pubmed: 19042497
Int J Nurs Stud. 2009 Apr;46(4):529-46
pubmed: 19233357
Cancer Treat Res. 2007;138:3-11
pubmed: 18080653
Pediatr Blood Cancer. 2007 Jan;48(1):80-5
pubmed: 16572406
Br Med Bull. 2018 Sep 1;127(1):83-89
pubmed: 30084904
J Cancer. 2012;3:217-25
pubmed: 22606211
US Obstet Gynecol. 2011 Jan 1;6(1):24-34
pubmed: 21927621
Reprod Biomed Online. 2013 Jul;27(1):96-103
pubmed: 23669017
Support Care Cancer. 2016 Jul;24(7):3191-9
pubmed: 26939923
J Assist Reprod Genet. 2010 May;27(5):227-31
pubmed: 20386978
Cancer. 2015 Oct 1;121(19):3499-506
pubmed: 26214755
Pediatr Blood Cancer. 2008 Mar;50(3):594-8
pubmed: 17514733
J Reprod Med. 2012 Sep-Oct;57(9-10):431-4
pubmed: 23091992
J Psychosom Obstet Gynaecol. 2013 Dec;34(4):170-8
pubmed: 24188788
Hum Reprod. 2004 Feb;19(2):460-2
pubmed: 14747198
Oncol Nurs Forum. 2015 Jan;42(1):34-43
pubmed: 25542319
Acta Oncol. 2012 Nov;51(8):1062-9
pubmed: 23050612
Support Care Cancer. 2016 Jan;24(1):163-171
pubmed: 25967235
J Cancer Surviv. 2010 Sep;4(3):279-83
pubmed: 20652434
Cancer Nurs. 2011 Jan-Feb;34(1):32-40
pubmed: 20697269
Oncologist. 2012;17(7):910-6
pubmed: 22707514
Ann Oncol. 2009 May;20 Suppl 4:178-81
pubmed: 19454448
Cancer. 2013 Nov 15;119(22):4044-50
pubmed: 24037854
Hum Reprod. 2014 Aug;29(8):1721-9
pubmed: 24916435
J Clin Oncol. 2016 May 20;34(15):1780-6
pubmed: 27044937
J Pediatr Hematol Oncol. 2012 Nov;34(8):e315-9
pubmed: 22983421
Cancer Med. 2016 Jun;5(6):1037-46
pubmed: 26899556
Ir Med J. 2011 Jan;104(1):6-9
pubmed: 21391329
J Pediatr Adolesc Gynecol. 2012 Apr;25(2):114-121
pubmed: 22222100
Cancer. 2018 May 1;124(9):1867-1876
pubmed: 29370455
Breast J. 2011 Jan-Feb;17(1):112-4
pubmed: 21129095
J Adolesc Health. 2009 Apr;44(4):394-400
pubmed: 19306799
Clin J Oncol Nurs. 2016 Aug 1;20(4):E93-9
pubmed: 27441525
Pediatrics. 2008 May;121(5):e1461-9
pubmed: 18450888
Cancer. 2012 Mar 15;118(6):1710-7
pubmed: 21887678
Hum Reprod. 2015 Sep;30(9):2022-30
pubmed: 26141713
Fertil Steril. 2008 Nov;90(5):1616-25
pubmed: 18054004
J Oncol Pract. 2012 Sep;8(5):303-8
pubmed: 23277768
Clin Pediatr Endocrinol. 2016 Apr;25(2):45-57
pubmed: 27212796
J Pediatr Hematol Oncol. 2011 Apr;33(3):203-7
pubmed: 21336166
J Natl Cancer Inst Monogr. 2005;(34):107-10
pubmed: 15784838
Br J Cancer. 2012 Mar 13;106(6):1053-61
pubmed: 22415294
Eur J Cancer Care (Engl). 2018 Jan;27(1):
pubmed: 27774666
Hum Fertil (Camb). 2003 May;6(2):A1-A39
pubmed: 12869793
J Adolesc Health. 2007 Jan;40(1):69-75
pubmed: 17185208
J Adolesc Health. 2014 May;54(5):527-35
pubmed: 24315429
Hum Fertil (Camb). 2018 Apr;21(1):3-26
pubmed: 29298394
J Psychosoc Oncol. 2012;30(4):387-401
pubmed: 22747104
J Assist Reprod Genet. 2011 Mar;28(3):269-77
pubmed: 21110080
J Natl Compr Canc Netw. 2013 Jan 1;11(1):71-7
pubmed: 23307983
Fertil Steril. 2011 May;95(6):1932-6
pubmed: 21371704
J Adolesc Young Adult Oncol. 2014 Jun 1;3(2):75-82
pubmed: 24940531
J Pediatr Oncol Nurs. 2007 Sep-Oct;24(5):255-63
pubmed: 17827491
Eur J Oncol Nurs. 2016 Apr;21:146-52
pubmed: 26481504
J Pediatr Oncol Nurs. 2008 Mar-Apr;25(2):97-101
pubmed: 18353752
Health Care Women Int. 2013;34(1):50-67
pubmed: 23216096
J Adolesc Young Adult Oncol. 2016 Sep;5(3):292-6
pubmed: 26978683
Ann Surg Oncol. 2016 May;23(5):1530-6
pubmed: 26790670
J Natl Compr Canc Netw. 2011 Nov;9(11):1219-25
pubmed: 22056654
J Adolesc Young Adult Oncol. 2015 Jun;4(2):84-90
pubmed: 26812556
Int J Clin Oncol. 2016 Dec;21(6):1183-1190
pubmed: 27402102
J Assist Reprod Genet. 2015 Aug;32(8):1171-8
pubmed: 26126877
J Cancer Educ. 2012 Jun;27(2):369-76
pubmed: 22259068
Int J Nurs Stud. 2012 Jan;49(1):47-53
pubmed: 21835406
J Pediatr Hematol Oncol. 2016 Mar;38(2):118-22
pubmed: 26630536
Bull Cancer. 2013 Jul-Aug;100(7-8):727-35
pubmed: 23835271
J Reprod Med. 2009 Apr;54(4):203-7
pubmed: 19438160
Neth J Med. 2014 Jun;72(5):264-70
pubmed: 24930460
Pediatr Blood Cancer. 2009 Sep;53(3):386-91
pubmed: 19489059
J Clin Oncol. 2012 Jun 10;30(17):2147-53
pubmed: 22585695
J Natl Compr Canc Netw. 2023 Aug;21(8):851-880
pubmed: 37549914
Eur J Cancer Care (Engl). 2010 Sep;19(5):610-20
pubmed: 20088919
Eur J Cancer Care (Engl). 2014 Jul;23(4):514-22
pubmed: 24372983
Future Oncol. 2016 Oct;12(19):2175-7
pubmed: 27513104
J Cancer Surviv. 2012 Sep;6(3):324-32
pubmed: 22752834
Cancer Treat Res. 2010;156:469-70
pubmed: 20811857
Eur J Cancer Care (Engl). 2009 Jul;18(4):381-90
pubmed: 19594609
J Natl Compr Canc Netw. 2016 Mar;14(3):301-9
pubmed: 26957616
Hum Reprod. 2012 Nov;27(11):3132-9
pubmed: 22926842
Patient Educ Couns. 2009 Dec;77(3):338-43
pubmed: 19796912
Eur J Oncol Nurs. 2018 Jun;34:42-48
pubmed: 29784137
Pediatr Blood Cancer. 2010 Dec 15;55(7):1356-61
pubmed: 20730881
J Adolesc Young Adult Oncol. 2016 Sep;5(3):232-9
pubmed: 26981709
Hum Fertil (Camb). 2008 Dec;11(4):238-45
pubmed: 19085260
Chin J Cancer. 2015 Jan;34(1):56-60
pubmed: 25556619
J Urol. 2012 Mar;187(3):979-86
pubmed: 22264454
J Psychosoc Oncol. 2015;33(4):333-53
pubmed: 25996581
Ann Oncol. 2011 May;22(5):1209-1214
pubmed: 21030380
J Psychosoc Oncol. 2012;30(3):331-46
pubmed: 22571247
J Pediatr Adolesc Gynecol. 2014 Aug;27(4):202-9
pubmed: 24746920
Fertil Steril. 2016 Dec;106(7):1763-1771.e1
pubmed: 27678034
Hum Reprod. 2014 Oct 10;29(10):2228-37
pubmed: 25069500
Hum Fertil (Camb). 2012 Sep;15(3):121-8
pubmed: 22746362
Psychooncology. 2012 Nov;21(11):1244-9
pubmed: 21755572
J Cancer Educ. 2012 Jun;27(2):362-8
pubmed: 22234424
Patient Educ Couns. 2008 Sep;72(3):402-10
pubmed: 18621502
Br J Cancer. 2013 Apr 30;108(8):1602-15
pubmed: 23579214
Arch Dis Child Educ Pract Ed. 2014 Aug;99(4):138-43
pubmed: 24639409
Pediatr Blood Cancer. 2013 Dec;60(12):1996-2000
pubmed: 23836521
J Adolesc Young Adult Oncol. 2018 Aug;7(4):509-513
pubmed: 29733237
Ann Surg Oncol. 2016 Nov;23(12):3850-3859
pubmed: 27431414
Aust Health Rev. 2016 Apr;40(2):210-212
pubmed: 26210890
J Obstet Gynaecol Can. 2012 Sep;34(9):849-858
pubmed: 22971454
Fertil Steril. 2013 Dec;100(6):1673-80
pubmed: 23987516
Support Care Cancer. 2015 Feb;23(2):333-41
pubmed: 25082365
Hum Reprod. 2012 Jul;27(7):2076-81
pubmed: 22552688
Support Care Cancer. 2017 Apr;25(4):1079-1085
pubmed: 27889828
Curr Oncol. 2015 Aug;22(4):e294-304
pubmed: 26300680
Psychooncology. 2018 Feb;27(2):401-409
pubmed: 28734119
Arch Gynecol Obstet. 2011 Aug;284(2):427-35
pubmed: 21431846
Int J Nurs Pract. 2009 Aug;15(4):311-7
pubmed: 19703048
Cancer. 2016 Jul 1;122(13):2101-9
pubmed: 27213483
Res Theory Nurs Pract. 2013;27(4):257-75
pubmed: 24552086
Hum Reprod. 2008 Oct;23(10):2246-51
pubmed: 18614615
J Oncol Pract. 2015 Mar;11(2):137-44
pubmed: 25549654
Eur J Cancer Care (Engl). 2018 Jan;27(1):
pubmed: 26676921
Bone Marrow Transplant. 2014 Apr;49(4):477-84
pubmed: 24419521
Hum Fertil (Camb). 2013 Mar;16(1):54-8
pubmed: 23509856
JCO Glob Oncol. 2020 Mar 2;6:
pubmed: 32259159
J Psychosom Obstet Gynaecol. 2010 Sep;31(3):150-7
pubmed: 20718586
Hum Reprod. 2011 Oct;26(10):2791-8
pubmed: 21778285
J Surg Oncol. 2017 Feb;115(2):116-121
pubmed: 27966219
BMC Cancer. 2016 Aug 09;16:620
pubmed: 27506811
Psychooncology. 2014 Jan;23(1):20-6
pubmed: 24038590
Eur J Cancer Care (Engl). 2014 Mar;23(2):189-98
pubmed: 24138775
J Cancer Educ. 2013 Mar;28(1):197-208
pubmed: 23225072
J Natl Compr Canc Netw. 2013 Dec 1;11(12):1504-9
pubmed: 24335685
J Assist Reprod Genet. 2012 Jun;29(6):465-8
pubmed: 22648282
BJOG. 2012 Aug;119(9):1049-57
pubmed: 22642563
J Clin Oncol. 2009 Dec 10;27(35):5952-7
pubmed: 19826115
J Adolesc Young Adult Oncol. 2016 Mar;5(1):58-63
pubmed: 26812454
J Cancer Surviv. 2012 Jun;6(2):200-9
pubmed: 22179785
Psychooncology. 2011 Oct;20(10):1044-52
pubmed: 20818600
Clin J Oncol Nurs. 2007 Jun;11(3):381-6
pubmed: 17623622
J Cancer Educ. 2018 Jun;33(3):528-535
pubmed: 27671919
J Adolesc Young Adult Oncol. 2015 Dec;4(4):213-8
pubmed: 26697271
Clin Breast Cancer. 2012 Apr;12(2):127-32
pubmed: 22444719
Psychooncology. 2009 Sep;18(9):1011-4
pubmed: 19061198
J Clin Oncol. 2013 Jul 1;31(19):2500-10
pubmed: 23715580
J Psychosoc Oncol. 2011;29(3):274-85
pubmed: 21590573
J Cancer Surviv. 2014 Dec;8(4):533-8
pubmed: 24806262
Hum Fertil (Camb). 2014 Dec;17(4):289-96
pubmed: 25180447